CTI BIOPHARMA CORP.

Main Information

Company Name CTI BIOPHARMA CORP.
Foreign Legal Name -
Entity Type:
Business Id 2014012700762
Company Status Expired
Domicile State Indiana
Creation Date 2014-01-27
Original Formation Date 2024-05-13
Inactive Date 2014-09-24
Report Due Date
Renewal Date -
Years Due

About Company

CTI BIOPHARMA CORP. operates as a with business ID 1057771.

CTI BIOPHARMA CORP. was formed on Monday 27th January 2014, so this company age is ten years, three months and sixteen days. This company status is currently expired .

Check more cti companies.

QR Code

Scan QR Code below with qrcode app on your smarthpone to get CTI BIOPHARMA CORP. data.

CTI BIOPHARMA CORP. on map

Address

Principal Office Address: -
Applicant Address: 150 W MARKET ST, STE 800, INDIANAPOLIS, IN, 46204, USA

Company Agent

Name -
Type -
Address -

Incorporators

Name Title Address
No records in database

Principals

Name Title Address
No records in database

Filings

Type Filing Date Effective Date Filling Number
Name Reservation 2014-01-27 2014-01-27 0005181774
Name Renewal 2014-05-27 2014-05-27 0005181775

Previous Names

Name Filing Date Effective Date Filling Number
No records in database

Nearby Comanies

NameAddressStatus

Similar Companies By Name

NameAddressStatus
CTI - INC. 2209 S CENTER ST, TERRE HAUTE, IN, 47802, USA Admin Dissolved
CTI ACQUISITION CO., INC. Merged
CTI ADMINISTRATORS, INC. 100 Court Ave, STE 306, DES MOINES, IA, 50309, USA Withdrawn
CTI AND ASSOCIATES, INC. 51331 W. PONTIAC TRAIL, WIXOM, MI, 48393, USA Active
CTI BILLING SOLUTIONS, INC. 333 N ALABAMA ST STE 240, INDIANAPOLIS, IN, 46204, USA Merged
CTI BIOPHARMA CORP. 3101 WETSERN AVE, SUITE 600, SEATTLE, WA, 98121, USA Withdrawn
CTI BIOPHARMA CORP. Expired
CTI BUILDING, LLC Admin Dissolved
CTI COLLECTION TRAINING INSTITUTE, LLC 9C MARKET PL CT, PALM COAST, FL, 32137, USA Revoked
CTI COMMUNICATIONS, INC. OF INDIANA 4215 Edison Lakes Parkway, Suite 200, MISHAWAKA, IN, 46545, USA Merged

CTI BIOPHARMA CORP. Reviews

Be the first to comment

0 comments